Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.
Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...
While new technology is making it more powerful, it remains underutilised due to low awareness levels. Increasing education ...
India, March 21 -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today ...
He retrieves the vials and needles for his twice-weekly fix: 250 milligrams of a steroid called nandrolone phenylpropionate and 250mg of testosterone. “Without this guy on YouTube, I would probably be ...
Rhythm Pharmaceuticals’ setmelanotide receives US FDA approval to treat patients living with acquired hypothalamic obesity: Boston Saturday, March 21, 2026, 18:00 Hrs [IST] Rhyt ...
Semaglutide is not just a glucose-lowering drug -- it improves weight and has proven cardiovascular, liver, and renal benefits. ​​Wider availability could therefore help reduce long-term complications ...
Global veterinary leaders unite in a Prevention Pledge urging year-round parasite control as fleas, ticks, and worms spread, raising emerging disease risks for pets and people. More than 40 veterinary ...
Learn how people with polymyalgia rheumatica can manage symptoms with self-injections. Get best practices for self-injections ...